Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › rotavirus

Rotavirus

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for rotavirus

8 trials tracked for rotavirus: 7 in phase 3 or 4 and 1 with published results. The most-cited published study has 5 citations.

8Trials tracked
7Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 2 Phase 3 5 Other / NA 1
  1. Phase 4 Evaluation of Immunogenicity and Safety of the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) Vaccine Squarekids Co-administered With GSK Biologicals' Human Rotavirus (HRV) Vaccine Rotarix (GSK444563) in Healthy Infants Completed · 5 cited
  2. Phase 4 Immunogenicity and Safety of Concomitant Administration of RotaTeq™ (V260) and the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus Vaccine (DTP-IPV) in Healthy Japanese Infants (V260-060) Completed
  3. Phase 3 Immunogenicity, Reactogenicity and Safety Study of Two Different Formulations of GSK Biologicals' Human Rotavirus Vaccine, Rotarix, in Healthy Infants Completed
  4. Phase 3 Safety,Tolerability and Immunogenicity of Vaccination With Rotateq in Healthy Infants in India (V260-021) Completed
  5. Phase 3 Phase III Placebo-controlled Study of V260 (RotaTeq™) in Japanese Healthy Infants (V260-029)(COMPLETED) Completed
  6. Phase 3 V260 Registration Study (V260-013)(COMPLETED) Completed
Show 2 more trials
  1. Phase 3 V260 Study: Concomitant Use of V260 and INFANRIX™ Hexa in Healthy Infants (V260-010) Completed
  2. N/A Effectiveness of Monovalent Rotavirus Vaccine (RV1) Completed

Showing the 8 most-cited and recently-updated of 8 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Modeling study projects rotavirus hospitalizations rise if vaccine coverage drops to 20% in US
Infectious Disease
Modeling study projects rotavirus hospitalizations rise if vaccine coverage drops to 20% in US New vaccine policy shift could trigger 200,000 hospitalizations
This modeling study examines rotavirus hospitalization trends in the United States under varying vaccine coverage scenarios.
A new policy change could lead to over 200,000 hospitalizations for infants in the next five years.
medRxiv Apr 28, 2026
Vaccines show protective effects against rotavirus and pneumococcal disease in sub-Saharan African children
Infectious Disease Meta-analysis
Vaccines show protective effects against rotavirus and pneumococcal disease in sub-Saharan African children Vaccine Results Might Be Wrong Without These Factors
This systematic review and meta-analysis of 64 studies assessed vaccine effectiveness in children under five years in sub-Saharan Africa.
Vaccine studies in Africa often miss other health changes happening at the same time, which can make shots look more effective than they rea…
medRxiv Apr 14, 2026